Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.
Authors: Jokic V; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Savic-Vujovic K; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Spasic J; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Bukumiric Z; Department of Statistics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Marinkovic M; Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Radosavljevic D; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Cavic M; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
Source: Dose-response : a publication of International Hormesis Society [Dose Response] 2022 Aug 04; Vol. 20 (3), pp. 15593258221117354. Date of Electronic Publication: 2022 Aug 04 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 101308899 Publication Model: eCollection Cited Medium: Print ISSN: 1559-3258 (Print) Linking ISSN: 15593258 NLM ISO Abbreviation: Dose Response Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35958274
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jokic+V%22">Jokic V</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Savic-Vujovic+K%22">Savic-Vujovic K</searchLink>; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Spasic+J%22">Spasic J</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Bukumiric+Z%22">Bukumiric Z</searchLink>; Department of Statistics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Marinkovic+M%22">Marinkovic M</searchLink>; Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Radosavljevic+D%22">Radosavljevic D</searchLink>; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Cavic+M%22">Cavic M</searchLink>; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308899%22">Dose-response : a publication of International Hormesis Society</searchLink> [Dose Response] 2022 Aug 04; Vol. 20 (3), pp. 15593258221117354. <i>Date of Electronic Publication: </i>2022 Aug 04 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308899 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1559-3258 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215593258%22">15593258 </searchLink><i>NLM ISO Abbreviation: </i>Dose Response <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35958274
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/15593258221117354
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 15593258221117354
    Titles:
      – TitleFull: Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jokic V
      – PersonEntity:
          Name:
            NameFull: Savic-Vujovic K
      – PersonEntity:
          Name:
            NameFull: Spasic J
      – PersonEntity:
          Name:
            NameFull: Bukumiric Z
      – PersonEntity:
          Name:
            NameFull: Marinkovic M
      – PersonEntity:
          Name:
            NameFull: Radosavljevic D
      – PersonEntity:
          Name:
            NameFull: Cavic M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 08
              Text: 2022 Aug 04
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1559-3258
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Dose-response : a publication of International Hormesis Society
              Type: main
ResultId 1